<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01800786</url>
  </required_header>
  <id_info>
    <org_study_id>OSAM</org_study_id>
    <secondary_id>K23HL103850-01</secondary_id>
    <nct_id>NCT01800786</nct_id>
  </id_info>
  <brief_title>Memory Consolidation in Obstructive Sleep Apnea</brief_title>
  <official_title>Memory Consolidation in Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overarching goal of the research proposed here is to test the hypothesis (i) that the
      pathophysiological mechanisms of OSA lead to deterioration in sleep-dependent memory
      consolidation across memory systems, with the genetic marker APOε4 as a modulator, and (ii)
      that CPAP can reverse some or all of these measured memory deficits.

      In addition, we are exploring which aspects of OSA (e.g., changes in sleep architecture,
      measures of hypoxemia, or the EEG power spectrum) most likely impact sleep-dependent memory
      processing.To this end, we are using specific cognitive tasks for which sleep-dependent
      memory consolidation processes have previously been demonstrated by our group and others. In
      addition, we are carrying out quantitative EEG power spectral analyses, to delineate abnormal
      functioning of brain regions with more precision.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2011</start_date>
  <completion_date type="Actual">June 30, 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overnight Change in Declarative Memory Performance</measure>
    <time_frame>3 months</time_frame>
    <description>At 3 months, we compared average overnight changes between evening and morning performance on a declarative memory test between untreated OSA subjects and those who received CPAP therapy for 3 months.
Positive numbers represent an increase in performance.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>OSA-CPAP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OSA patient will use CPAP for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OSA -no CPAP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>newly diagnosed OSA patient will not wear CPAP for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <arm_group_label>OSA-CPAP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Subject selection

        General inclusion criteria:

          -  Men and women ages 18 to 80 years old

          -  Good health as determined by a medical and psychiatric history and physical
             examination

          -  An absence of any medical or psychiatric disorders (other than OSA and treated
             hypertension) that could influence excessive daytime sleepiness

          -  The ability to complete self-rating scales and computer-based testing

          -  Beck Depression Inventory score ≤16

          -  Healthy controls will be excluded with and Epworth Sleepiness Scale (ESS) score &gt;
             10/24, OSA patients will be excluded from randomization with an ESS score &gt;18/24.

          -  Subjects must agree to abstain from alcohol consumption from the day before and
             throughout Session 1 and Session 2.

        Criteria for OSA patients:

          -  Newly diagnosed with OSA and with no prior exposure to CPAP

          -  Quantified apnea-hypopnea index greater than 5/hr (AHI, defined as the number of
             apneas and/or hypopneas per hour of sleep)

          -  Subjects must agree to limit alcohol use between Session 1 and Session 2 to one or
             fewer alcoholic drinks daily or up to 4 drinks weekly

        Criteria for Healthy control group:

        • Subjects will be matched to the obstructive sleep apnea patient group for age, race, body
        mass index, education and intelligence (WAIS - full scale)

        Subgroup selection:

        An additional subgroup of OSA patients and controls, who are taking antidepressants, will
        be recruited. Except for the current treatment with antidepressants all other exclusion and
        exclusion criteria will be applied.

        The following classes of antidepressants will be eligible:

          -  Selective serotonin reuptake inhibitors

          -  Serotonin-norepinephrine reuptake inhibitors

          -  Noradrenergic and specific serotonergic antidepressants

          -  Norepinephrine-dopamine reuptake inhibitors

        Exclusion criteria

        ALL PARTICIPANTS:

        Potential participants (OSA patients and controls) are excluded if one or more of the
        following conditions are found:

          -  Any history of clinically significant, uncontrolled medical or psychiatric condition
             (treated or untreated), other than OSA and hypertension (self-report)

          -  History of serious heart disease or renal failure (self-report)

          -  History of head injury (self-report)

          -  Inability to type (e.g., physical disability, arthritis) or to exercise

          -  A lifetime history of alcohol, narcotic or any other drug abuse (self-report)

          -  Use of medications, over-the counter drugs or nutritional supplements known to have an
             effect on sleep, cognition and/or daytime vigilance (self-report)

          -  Female subjects who are pregnant cannot take part in the study. If a female subject
             becomes pregnant during the study, she will have to stop participation

          -  Presence of any of the following sleep disorders:

               -  Cheyne-Stokes breathing or central sleep apnea (&gt; 10% of events central)
                  (screening sleep study)

               -  Circadian rhythm disorder (structured interview)

               -  REM sleep without atonia or REM behavior disorder (structured interview and
                  screening sleep study )

               -  Parasomnias (structured interview)

               -  PLMS index of &gt;15/h (screening sleep study)

               -  Insomnia (structured interview and 2 weeks sleep diaries)

               -  Narcolepsy (structured interview)

          -  Left-handedness (only MSLT participants)- (self-report)

          -  uncorrected vision impairment and/or visual field defect (self report, screening
             examination)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ina Djonlagic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2013</study_first_submitted>
  <study_first_submitted_qc>February 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2013</study_first_posted>
  <results_first_submitted>March 10, 2017</results_first_submitted>
  <results_first_submitted_qc>May 8, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 6, 2017</results_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Ina E. Donlagic</investigator_full_name>
    <investigator_title>Associate Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>OSA-CPAP Group</title>
          <description>OSA patient will use CPAP for 3 months
CPAP= continuous positive airway pressure therapy
OSA= obstructive sleep apnea</description>
        </group>
        <group group_id="P2">
          <title>OSA -no CPAP</title>
          <description>newly diagnosed OSA patient will not wear CPAP for 3 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>OSA-CPAP Group</title>
          <description>OSA patient will use CPAP for 3 months
CPAP= continuous positive airway pressure therapy
OSA= obstructive sleep apnea</description>
        </group>
        <group group_id="B2">
          <title>OSA -no CPAP</title>
          <description>newly diagnosed OSA patient will not wear CPAP for 3 months</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.7" spread="12.4"/>
                    <measurement group_id="B2" value="46.4" spread="13"/>
                    <measurement group_id="B3" value="47.9" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overnight Change in Declarative Memory Performance</title>
        <description>At 3 months, we compared average overnight changes between evening and morning performance on a declarative memory test between untreated OSA subjects and those who received CPAP therapy for 3 months.
Positive numbers represent an increase in performance.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>OSA-CPAP Group</title>
            <description>OSA patient will use CPAP for 3 months
CPAP= continuous positive airway pressure therapy
OSA= obstructive sleep apnea</description>
          </group>
          <group group_id="O2">
            <title>OSA -no CPAP</title>
            <description>newly diagnosed OSA patient will not wear CPAP for 3 months</description>
          </group>
        </group_list>
        <measure>
          <title>Overnight Change in Declarative Memory Performance</title>
          <description>At 3 months, we compared average overnight changes between evening and morning performance on a declarative memory test between untreated OSA subjects and those who received CPAP therapy for 3 months.
Positive numbers represent an increase in performance.</description>
          <units>percent change in performance</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2" spread="0.8"/>
                    <measurement group_id="O2" value="6.5" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>OSA-CPAP Group</title>
          <description>OSA patient will use CPAP for 3 months
CPAP= continuous positive airway pressure therapy
OSA= obstructive sleep apnea</description>
        </group>
        <group group_id="E2">
          <title>OSA -no CPAP</title>
          <description>newly diagnosed OSA patient will not wear CPAP for 3 months</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ina Djonlagic</name_or_title>
      <organization>Brigham and Women's Hospital</organization>
      <phone>617 667 5129</phone>
      <email>idjonlag@bidmc.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

